Phenyl aminosalicylate

Pheny-pas-tebamin (phenyl aminosalicylate) is a small molecule pharmaceutical. Phenyl aminosalicylate was first approved as Pheny-pas-tebamin on 1982-01-01.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

No data

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Phenyl aminosalicylate

Tradename	Company	Number	Date	Products
PHENY-PAS-TEBAMIN	Pharmaceutical Research Associates Inc	N-011695 DISCN	1982-01-01	2 products

Hide discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

No data

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

No data

HCPCS

No data

Clinical

No data

Drug

General

Drug common name	Phenyl aminosalicylate
INN	fenamisal
Description	4-amino-2-hydroxybenzoic acid phenyl ester is a carbonyl compound.
Classification	Small molecule
Drug class	anti-inflammatory agents (salicylic acid derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	Nc1ccc(C(=O)Oc2ccccc2)c(O)c1